Ocak, B. 2020. The Clinical Importance of Fibroblast Growth Factor 23 on Advanced Non-small Cell Lung Cancer Patients Without Druggable Alterations in Genes as EGFR or ALK or ROS1 Fibroblast Growth Factor 23 and Non-small Cell Lung Cancer. Eurasian Journal of Medical Investigation , vol.4 , 365-369.

Ocak, B., (2020). The Clinical Importance of Fibroblast Growth Factor 23 on Advanced Non-small Cell Lung Cancer Patients Without Druggable Alterations in Genes as EGFR or ALK or ROS1 Fibroblast Growth Factor 23 and Non-small Cell Lung Cancer. Eurasian Journal of Medical Investigation , vol.4, 365-369.

Ocak, BİROL. "The Clinical Importance of Fibroblast Growth Factor 23 on Advanced Non-small Cell Lung Cancer Patients Without Druggable Alterations in Genes as EGFR or ALK or ROS1 Fibroblast Growth Factor 23 and Non-small Cell Lung Cancer," Eurasian Journal of Medical Investigation , vol.4, 365-369, 2020

Ocak, BİROL. "The Clinical Importance of Fibroblast Growth Factor 23 on Advanced Non-small Cell Lung Cancer Patients Without Druggable Alterations in Genes as EGFR or ALK or ROS1 Fibroblast Growth Factor 23 and Non-small Cell Lung Cancer." Eurasian Journal of Medical Investigation , vol.4, pp.365-369, 2020

Ocak, B. (2020) . "The Clinical Importance of Fibroblast Growth Factor 23 on Advanced Non-small Cell Lung Cancer Patients Without Druggable Alterations in Genes as EGFR or ALK or ROS1 Fibroblast Growth Factor 23 and Non-small Cell Lung Cancer." Eurasian Journal of Medical Investigation , vol.4, pp.365-369.

@article{article, author={BİROL OCAK}, title={The Clinical Importance of Fibroblast Growth Factor 23 on Advanced Non-small Cell Lung Cancer Patients Without Druggable Alterations in Genes as EGFR or ALK or ROS1 Fibroblast Growth Factor 23 and Non-small Cell Lung Cancer}, journal={Eurasian Journal of Medical Investigation}, year=2020, pages={365-369} }